FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/04/065340 [Registered on: 08/04/2024] Trial Registered Prospectively
Last Modified On: 01/04/2024
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Behavioral 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   "Beating Type 2 Diabetes: An integrated approach through behavioural and dietary interventions to achieve remission  
Scientific Title of Study   Remission of Type 2 Diabetes Mellitus through Dietary and Behavioural interventions: A Randomised controlled Trial 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
INT/IEC/2024/SPL 67 Version 1 dated 18 Feb 24  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Arunjeet Singh 
Designation  PhD Scholar 
Affiliation  PGIMER Chandigarh  
Address  Dept of communuity Medicine and School of Public Health PGIMER Chandigarh

Chandigarh
CHANDIGARH
160012
India 
Phone  9168203366  
Fax    
Email  warinmytime@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Prof JS Thakur 
Designation  Professor  
Affiliation  PGIMER Chandigarh  
Address  Dept of communuity Medicine and School of Public Health PGIMER Chandigarh

Chandigarh
CHANDIGARH
160012
India 
Phone  9463602173  
Fax    
Email  jsthakur64@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Arunjeet Singh 
Designation  PhD Scholar 
Affiliation  PGIMER Chandigarh  
Address  Dept of communuity Medicine and School of Public Health PGIMER Chandigarh
Dept of communuity Medicine and School of Public Health PGIMER Chandigarh
Chandigarh
CHANDIGARH
160012
India 
Phone  9168203366  
Fax    
Email  warinmytime@gmail.com  
 
Source of Monetary or Material Support  
Implementation reserach grant of Rs 25,000 by World NCD Federation. The study will be conducted. The study will be conducted in Indira colony , field practice area of Dept of community medicine and school of public health PGIMER  
 
Primary Sponsor  
Name  Implementation Research Grant of Rs 25,000 won for conducting Doctoral work  
Address  11 Karuna Sadan Building Sector 11 A Chandigarh 
Type of Sponsor  Other [NGO ] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Arunjeet Singh  Indira Colony , Manimajra , UT of Chandigarh  Urban Health Training Centre Dept of Community Medicine and School of Public Health PGIMER Chandigarh
Chandigarh
CHANDIGARH 
9168203366

warinmytime@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
PGIMER Institutional Ethics Committe   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: E119||Type 2 diabetes mellitus without complications,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Dietary and Behavioural intyervention   Intervention in the study will start with baseline assessment of eligible participants for enrolment in the trial. Randomisation of eligible participants in each of the arms will be done through stratified randomisation in which the participants in the intervention and control arm will be further sub stratified having Type 2 Diabetes Mellitus less than and more than 2 years. Randomised withdrawal design may be considered in our study in which case the total sample size will be 100 The dietary intervention in the case will be consisting of a millet-based diet, low carbohydrate diets and a overall emphasis on a balanced diet will be reinforced. The dietary intervention in the instant case will be designed keeping the purchasing power of the participants in perspective Behavioural change intervention will be done through promotion of physical activity smoking cessation and alcohol cessation. The physical activity will be for 60 minutes daily as per the recommendation of guidelines on physical activity and sedentary behaviour. The comparator in the study will continue to receive standard care. The intervention arm will be dietary and behavioural intervention and comparator arm will continue to receive the standard care . The total duration of the intervention is 9 months  
Comparator Agent  The Comparator agent in our trial will be standard care in which the patient will continue to receive the treatment as prescribed by the physician   The comparator in our case will be standard care which the patients will continue to receive . In that way we will ensure that the patients in comparator arm will continue to receive the care and are not at a disadvantage. The total duration of the intervention is 9 months  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  Patients willing to participate in the study

Patients satisfying the diagnostic criteria of Type 2 Diabetes Mellitus as per HEARTS D Module and World NCD Federation guidelines

 
 
ExclusionCriteria 
Details  Patients unwilling to participate in the study
Patients with Type 1 Diabetes
Pre-diabetes
Patients on Insulin
 
 
Method of Generating Random Sequence   Random Number Table 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
(a) Number of patients with behavioural and dietary interventions who achieved remission in patients
(b) What is acceptability and understand barriers to adopt dietary interventions especially millets
(c) IEC material in hindi the form of hand bills/ booklets for promotion and acceptability of dietary and behavioural interventions
 
(a) Number of patients with behavioural and dietary interventions who achieved remission in patients
(b) What is acceptability and understand barriers to adopt dietary interventions especially millets
(c) IEC material in hindi the form of hand bills/ booklets for promotion and acceptability of dietary and behavioural interventions

The patients will be assessed at baseline , 3 months , 6 months and 9 months
 
 
Secondary Outcome  
Outcome  TimePoints 
Number of patients with Hypertension who became normotensive at the end of 9th month   The data pertaining to hypertensive patients became normotensive at the end of 9th month 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   27/04/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="9"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   The study titled " Achieving remission in patients with Type 2 Diabetes Mellitus through Behavioural and dietary interventions : A Randomised Control Trial"  will begin with recruitment after permission is received from CTRI . The primary  study objective  is to acheive remission in patients with Type 2 Diabetes Mellitus using dietary and behavioural interventions . The dietary intervention will consist of administration of a Millet based and a low carbohydrate diet , the behavioural  intervention will include graded assimilation of physical activity , yoga session , awareness about diabetes and associated complications, tobacco and alcohol cessation . IEC activities will be conducted in the form of face to face interviews and group sessions . The intervention will be  for 6 months  and subsequently the patients will be randomised into intervention and control  group at the end of sixth month and will be followed up for further 3 months,  The end of trial assessment will be carried out at the end of 9th month in which remission status acheived will be observed . The number of study sites in the trial will be 1 and prior permission of IEC of PGIMER Chandigarh has been obtained  
Close